Screener
Asset Entities ASST Medical Device — Nonoperating Income (Expense)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Change in fair value on long-term notes payable, at fair value | (299) | — |
| Gain on extinguishment of debt | 30 | — |
| Transaction costs | — | (5,437) |
| Total other income/(expense) | 646 | (5,185) |
| Net loss before income taxes | (257,603) | (8,875) |
| Income tax benefit/(expense) | — | — |
| Net loss | $(257,603) | $(8,875) |
| Dividends on preferred stock | (26,209) | — |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — nonoperating income (expense)?
- Asset Entities (ASST) reported medical device — nonoperating income (expense) of $270K in Q2 2026.
- What does medical device — nonoperating income (expense) mean?
- Captures financial results from activities outside the core medical device operations, such as investment income, currency fluctuations, or one-time charges. It provides a clearer view of the segment's underlying operational performance by isolating non-core items.
Ask your AI about Asset Entities's medical device — nonoperating income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude